Elucidation of Early Evolution of HIV-1 Group M in the Congo Basin Using Computational Methods.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
02 04 2021
Historique:
received: 02 02 2021
revised: 26 03 2021
accepted: 26 03 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 12 8 2021
Statut: epublish

Résumé

The Congo Basin region is believed to be the site of the cross-species transmission event that yielded HIV-1 group M (HIV-1M). It is thus likely that the virus has been present and evolving in the region since that cross-species transmission. As HIV-1M was only discovered in the early 1980s, our directly observed record of the epidemic is largely limited to the past four decades. Nevertheless, by exploiting the genetic relatedness of contemporary HIV-1M sequences, phylogenetic methods provide a powerful framework for investigating simultaneously the evolutionary and epidemiologic history of the virus. Such an approach has been taken to find that the currently classified HIV-1 M subtypes and Circulating Recombinant Forms (CRFs) do not give a complete view of HIV-1 diversity. In addition, the currently identified major HIV-1M subtypes were likely genetically predisposed to becoming a major component of the present epidemic, even before the events that resulted in the global epidemic. Further efforts have identified statistically significant hot- and cold-spots of HIV-1M subtypes sequence inheritance in genomic regions of recombinant forms. In this review we provide ours and others recent findings on the emergence and spread of HIV-1M variants in the region, which have provided insights into the early evolution of this virus.

Identifiants

pubmed: 33918115
pii: genes12040517
doi: 10.3390/genes12040517
pmc: PMC8065694
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 107752/Z/15/Z
Pays : United Kingdom

Références

J Virol. 2009 Dec;83(24):12917-24
pubmed: 19793809
J Virol. 2020 Dec 22;95(2):
pubmed: 33087461
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Infect Genet Evol. 2012 Mar;12(2):453-60
pubmed: 21565285
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
Science. 2006 Jul 28;313(5786):523-6
pubmed: 16728595
Genetics. 2010 Apr;184(4):1133-9
pubmed: 20124027
Nature. 1999 Feb 4;397(6718):436-41
pubmed: 9989410
Virus Evol. 2018 Feb 19;4(1):vey003
pubmed: 29484203
Virus Res. 2006 Sep;120(1-2):191-8
pubmed: 16621098
Infect Genet Evol. 2015 Oct;35:9-18
pubmed: 26190450
Nature. 2008 Oct 2;455(7213):661-4
pubmed: 18833279
Infect Genet Evol. 2009 Jul;9(4):672-82
pubmed: 18562253
Infect Genet Evol. 2016 Dec;46:190-199
pubmed: 27180893
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12222-12229
pubmed: 32430331
Infect Genet Evol. 2018 Sep;63:295-306
pubmed: 28951202
Retrovirology. 2010 Apr 28;7:39
pubmed: 20426823
Virology. 2009 Apr 25;387(1):229-34
pubmed: 19272628
Evol Med Public Health. 2015 Sep 09;2015(1):254-65
pubmed: 26354000
Virus Evol. 2017 Nov 10;3(2):vex032
pubmed: 29250430
Lancet HIV. 2020 Nov;7(11):e772-e781
pubmed: 33128904
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
Infect Genet Evol. 2007 Dec;7(6):717-23
pubmed: 17851137
Genetics. 2007 Apr;175(4):1773-85
pubmed: 17194781
Nature. 2001 Apr 26;410(6832):1047-8
pubmed: 11323659
PLoS Pathog. 2019 Dec 6;15(12):e1007976
pubmed: 31809523
J Virol. 2015 Dec 09;90(5):2221-9
pubmed: 26656688
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18566-70
pubmed: 17978186
AIDS Res Hum Retroviruses. 2020 Jul;36(7):574-582
pubmed: 32281388
EBioMedicine. 2015 Jan 28;2(3):244-54
pubmed: 26137563
PLoS One. 2014 Jun 17;9(6):e100400
pubmed: 24936864
Bioinformatics. 2010 Jun 15;26(12):i132-9
pubmed: 20529898
Science. 2000 Jun 9;288(5472):1789-96
pubmed: 10846155
Genetics. 2000 Oct;156(2):879-91
pubmed: 11014833
PLoS Pathog. 2009 May;5(5):e1000418
pubmed: 19424420
Science. 2014 Oct 3;346(6205):56-61
pubmed: 25278604
Nature. 1998 Feb 5;391(6667):594-7
pubmed: 9468138
PLoS One. 2014 Jun 11;9(2):e98908
pubmed: 24918930
FASEB J. 2001 Feb;15(2):276-8
pubmed: 11156935
BMC Evol Biol. 2016 Nov 16;16(1):249
pubmed: 27852214
Virus Evol. 2018 Jun 11;4(1):vey015
pubmed: 29942655
Mol Phylogenet Evol. 2016 Jan;94(Pt A):264-70
pubmed: 26358613
AIDS. 2009 Sep 10;23(14):F9-F17
pubmed: 19644346
Lancet Infect Dis. 2011 Jan;11(1):45-56
pubmed: 21126914

Auteurs

Marcel Tongo (M)

Center for Research on Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants (IMPM), Yaoundé, Cameroon.

Darren P Martin (DP)

Division of Computational Biology, Department of Integrative Biomedical Sciences and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.

Jeffrey R Dorfman (JR)

Division of Medical Virology, School of Pathology, Faculty of Health Sciences, Stellenbosch University, Cape Town 7505, South Africa.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH